Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors (Q39315508)

10 September 2017

title

Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors (English)

1 reference

10 September 2017

1 reference

R Omori

1

1 reference

10 September 2017

J Eguchi

2

1 reference

10 September 2017

K Hiroishi

3

1 reference

10 September 2017

S Ishii

4

1 reference

10 September 2017

A Hiraide

5

1 reference

10 September 2017

M Sakaki

6

1 reference

10 September 2017

H Doi

7

1 reference

10 September 2017

A Kajiwara

8

1 reference

10 September 2017

T Ito

9

1 reference

10 September 2017

M Kogo

10

1 reference

10 September 2017

M Imawari

11

1 reference

10 September 2017

publication date

13 July 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

19

1 reference

10 September 2017

issue

9

1 reference

10 September 2017

page(s)

637-643

1 reference

The Fas counterattack: cancer as a site of immune privilege

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Costimulation of T cells for tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Cytokines, tumour-cell death and immunogenicity: a question of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

Role of interferons and other cytokines in the regulation of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

7 January 2021

inferred from DOI database lookup

Interferon-α and interleukin-12 gene therapy of cancer: interferon-α induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

7 January 2021

inferred from DOI database lookup

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.42

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/CGT.2012.42

1 reference

release_zlr4aecsmndnten2f7mqjk7hgm

10 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zlr4aecsmndnten2f7mqjk7hgm

24 November 2022

mapped directly with Wikidata item

1 reference